Literature DB >> 9461077

Antigen distortion allows influenza virus to escape neutralization.

D Fleury1, S A Wharton, J J Skehel, M Knossow, T Bizebard.   

Abstract

The structure of the hemagglutinin (HA) of a mutant influenza virus that escapes neutralization by a monoclonal antibody shows that the mutation causes changes in HA structure which avoid an energetically less favorable conformation. However, the structure of the mutant HA.Fab complex indicates that the antibody binds selectively to mutant HA in a wild type-like distorted conformation. The association of an antibody with a less favored HA conformation represents an alternative to previously described mechanisms of escape from neutralization by antibodies.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9461077     DOI: 10.1038/nsb0298-119

Source DB:  PubMed          Journal:  Nat Struct Biol        ISSN: 1072-8368


  61 in total

1.  The principle of delivery of T cell epitopes to antigen-presenting cells applied to peptides from influenza virus, ovalbumin, and hen egg lysozyme: implications for peptide vaccination.

Authors:  I B Rasmussen; E Lunde; T E Michaelsen; B Bogen; I Sandlie
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-21       Impact factor: 11.205

2.  A computational analysis of the antigenic properties of haemagglutinin in influenza A H3N2.

Authors:  William D Lees; David S Moss; Adrian J Shepherd
Journal:  Bioinformatics       Date:  2010-04-13       Impact factor: 6.937

3.  Modeling the three-dimensional structures of an unbound single-chain variable fragment (scFv) and its hypothetical complex with a Corynespora cassiicola toxin, cassiicolin.

Authors:  Adeel Malik; Ahmad Firoz; Vivekanand Jha; Elumalai Sunderasan; Shandar Ahmad
Journal:  J Mol Model       Date:  2010-03-16       Impact factor: 1.810

4.  A structure-based benchmark for protein-protein binding affinity.

Authors:  Panagiotis L Kastritis; Iain H Moal; Howook Hwang; Zhiping Weng; Paul A Bates; Alexandre M J J Bonvin; Joël Janin
Journal:  Protein Sci       Date:  2011-02-16       Impact factor: 6.725

5.  Accumulation of amino acid substitutions promotes irreversible structural changes in the hemagglutinin of human influenza AH3 virus during evolution.

Authors:  Katsuhisa Nakajima; Eri Nobusawa; Alexander Nagy; Setsuko Nakajima
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

6.  Influenza A virus hemagglutinin trimerization completes monomer folding and antigenicity.

Authors:  Javier G Magadán; Surender Khurana; Suman R Das; Gregory M Frank; James Stevens; Hana Golding; Jack R Bennink; Jonathan W Yewdell
Journal:  J Virol       Date:  2013-07-03       Impact factor: 5.103

7.  A virus-like particle that elicits cross-reactive antibodies to the conserved stem of influenza virus hemagglutinin.

Authors:  Anette Schneemann; Jeffrey A Speir; Gene S Tan; Reza Khayat; Damian C Ekiert; Yumiko Matsuoka; Ian A Wilson
Journal:  J Virol       Date:  2012-08-15       Impact factor: 5.103

8.  Contribution of asparagine residues to the stabilization of a proteinaceous antigen-antibody complex, HyHEL-10-hen egg white lysozyme.

Authors:  Akiko Yokota; Kouhei Tsumoto; Mitsunori Shiroishi; Takeshi Nakanishi; Hidemasa Kondo; Izumi Kumagai
Journal:  J Biol Chem       Date:  2009-12-28       Impact factor: 5.157

9.  Genetic diversity of hemagglutinin gene of A(H1N1)pdm09 influenza strains isolated in Taiwan and its potential impact on HA-neutralizing epitope interaction.

Authors:  Krzysztof Łepek; Beata Pająk; Paweł Siedlecki; Marcin Niemcewicz; Janusz Kocik; Ho-Sheng Wu; Ji-Rong Yang; Krzysztof Kucharczyk; Bogusław Szewczyk
Journal:  Hum Vaccin Immunother       Date:  2014-01-09       Impact factor: 3.452

10.  A unique and conserved neutralization epitope in H5N1 influenza viruses identified by an antibody against the A/Goose/Guangdong/1/96 hemagglutinin.

Authors:  Xueyong Zhu; Yong-Hui Guo; Tao Jiang; Ya-Di Wang; Kwok-Hung Chan; Xiao-Feng Li; Wenli Yu; Ryan McBride; James C Paulson; Kwok-Yung Yuen; Cheng-Feng Qin; Xiao-Yan Che; Ian A Wilson
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.